References
- Fiorucci L, Ascoli F. Mast cell tryptase, a still enigmatic enzyme. Cell Mol Life Sci 2004; 61: 1278–1295
- Schwartz L B, Metcalfe D D, Miller J S, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987; 316: 1622–1626
- Cairns J A, Walls A F. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol 1996; 156: 275–283
- Brown J K, Tyler C L, Jones C A, Ruoss S J, Hartmann T, Caughey G H. Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells. Am J Respir Cell Mol Biol 1995; 13: 227–236
- Ruoss S J, Hartmann T, Caughey G H. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991; 88: 493–499
- Gruber B L, Kew R R, Jelaska A, Marchese M J, Garlick J, Ren S, et al. Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 1997; 158: 2310–2317
- Compton S J, Cairns J A, Holgate S T, Walls A F. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J Immunol 1998; 161: 1939–1946
- Schwartz L B, Sakai K, Bradford T R, Ren S, Zweiman B, Worobec A S, Metcalfe D D. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995; 96: 2702–2710
- Sperr W R, Jordan J H, Baghestanian M, Kiener H P, Samorapoompichit P, Semper H, et al. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 2001; 98: 2200–2209
- Sperr W R, Stehberger B, Wimazal F, Baghestanian M, Schwartz L B, Kundi M, et al. Serum tryptase measurements in patients with myelodysplastic syndromes. Leuk Lymphoma 2002; 43: 1097–1105
- Sperr W R, Mitterbauer M, Mitterbauer G, Kundi M, Jager U, Lechner K, et al. Quantitation of minimal residual disease in acute myeloid leukemia by tryptase monitoring identifies a group of patients with a high risk of relapse. Clin Cancer Res 2005; 11: 6536–6543
- Sonneck K, Florian S, Böhm A, Krauth M -T, Kondo R, Hauswirth A W, et al. Evaluation of biological activity of tryptase secreted from blast cells in acute myeloid leukemia. Leuk Lymphoma 2006; 47: 897–906